Pandemblock Oy
Developing preventive intranasal antivirals targeting respiratory viruses globally.
Overview
- Unknown
- Employees
- Unknown
- Revenue
- 2021
- Founded
Key Decision Makers
Pasi Kemppainen
Business Development and Partner Relations | Founder
Anna R. Mäkelä
CEO | Founder
Kalle Saksela
Scientific Advisor
Description
Pandemblock Ltd is a biotechnology company spun out from the University of Helsinki in the fall of 2021. The organization is dedicated to developing innovative, affordable antiviral intranasal inhibitors aimed at improving pandemic preparedness and control. Their core technology is the proprietary S...
Tags
Keywords
Company Information
- Industry
- Unknown
- Legal Form
- 16
- VAT Number
- FI32428191
Decision Makers
3 contacts in FunnelfeedrPasi Kemppainen
Business Development and Partner Relations | Founder
Anna R. Mäkelä
CEO | Founder
Other Contacts
Kalle Saksela
Scientific Advisor
Similar Companies
20 similar companies in Funnelfeedr
Virenc Holding AB
Developing novel peptide therapeutics against enveloped viruses for global health.
ROKOTE LABORATORIES FINLAND OY
Developing universal intranasal vaccines to block respiratory virus infection effectively.
1928 Diagnostics AB
8 employeesDelivering fast bioinformatics solutions to fight antimicrobial resistance effectively.
Gedea Biotech AB
5–9 employeesSwedish biotech developing antibiotic-free BV treatment pHyph.
QureTech Bio AB
5–9 employeesDeveloping novel synthetic antibiotics to combat drug-resistant bacteria.
Browse More
Pandemblock Oy Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo